Clinical Trials Logo

Autistic Disorder clinical trials

View clinical trials related to Autistic Disorder.

Filter by:
  • Active, not recruiting  
  • « Prev · Page 8

NCT ID: NCT01160783 Active, not recruiting - Clinical trials for Autism Spectrum Disorder

Genetic Contributions to Autism Spectrum Disorders

Start date: April 2007
Phase:
Study type: Observational

This study is working towards gaining a better understanding of the genetic and environmental factors involved in autism spectrum disorders (ASD), which includes autism, pervasive developmental disorder (PDD), and Asperger's syndrome. The investigators hope that information gained from this study will lead to new ways of diagnosing and treating ASDs.

NCT ID: NCT01031407 Active, not recruiting - Children Clinical Trials

Cognitive Neuroscience of Autism Spectrum Disorders

Start date: February 21, 2010
Phase:
Study type: Observational

Background: - Autism spectrum disorders (ASDs) are a group of developmental disorders that affect communication, social interaction, and behavior. Relatively little is known about the relationship between genetics and behavior among these individuals and their close relatives. Researchers are interested in using interviews and rating scales to better understand these issues, as well as collecting brain scan data and genetic samples for testing and comparison. - By comparing test results and genetic samples from healthy volunteers, people with ASD, and parents (or caregivers or legal guardians) of the first two groups, researchers hope to better understand the neuroscience of ASD. Objectives: - To learn more about the brain in healthy people and in people with autism spectrum disorders. - To study genes that might be involved in autism spectrum disorders by collecting DNA samples from participants. Eligibility: The following groups of participants will be eligible for the study: - Individuals between 5 and 89 years of age who have autism spectrum disorders. - Healthy volunteers between 5 and 89 years of age. - Cognitively impaired children between 5 and 17 years of age. - Parents/caregivers/legal guardians of individuals in the above three groups. Design: - Participants will visit the National Institutes of Health Clinical Center for research tests, which will be administered over multiple visits. Researchers will determine the specific tests to be administered based on the medical history of the study participant. - Researchers will study the brain through interviews, tests of thinking and memory (neuropsychological tests), brain imaging with magnetic resonance imaging (MRI), and magnetoencephalography (MEG). - The study will also collect blood or saliva to obtain a DNA sample.

NCT ID: NCT00910559 Active, not recruiting - Clinical trials for Autism Spectrum Disorders

Phenotypic and Genetic Factors in Autism Spectrum Disorders

Start date: July 2008
Phase:
Study type: Observational

The purpose of the study is to collect phenotypic (observable characteristics) and genetic information about individuals with Autism Spectrum Disorders (ASDs) and their families.

NCT ID: NCT00110708 Active, not recruiting - Autism Clinical Trials

Safety and Efficacy Study in the Treatment of Intestinal Problems Associated With Autism

Start date: April 2005
Phase: Phase 2
Study type: Interventional

The purpose of this study is to determine if human immunoglobulin given by mouth twice a day is effective in treating the persistent gastrointestinal (GI) problems such as diarrhea, constipation, abdominal pain, and bloating, in children with autism.